In a filing, Achieve Life Sciences Inc revealed its Chief Financial Officer Oki Mark K acquired Company’s shares for reported $28887.0 on Mar 17 ’25. In the deal valued at $2.89 per share,10,000 shares were bought. As a result of this transaction, Oki Mark K now holds 10,000 shares worth roughly $29800.0.
Then, Stewart Richard Alistair bought 10,000 shares, generating $28,598 in total proceeds. Upon buying the shares at $2.86, the Chieve Executive Officer now owns 60,876 shares.
Rodman & Renshaw initiated its Achieve Life Sciences Inc [ACHV] rating to a Buy in a research note published on November 14, 2024; the price target was $12. A number of analysts have revised their coverage, including Raymond James’s analysts, who began to cover the stock in late September with a ‘”a Strong buy”‘ rating. Maxim Group also remained covering ACHV and reiterated its “Buy” recommendation on May 10, 2023. Oppenheimer started covering the stock on June 23, 2021. It rated ACHV as “an Outperform”.
Price Performance Review of ACHV
On Tuesday, Achieve Life Sciences Inc [NASDAQ:ACHV] saw its stock fall -3.87% to $2.98. Over the last five days, the stock has lost -19.24%. Achieve Life Sciences Inc shares have fallen nearly -15.34% since the year began. Nevertheless, the stocks have fallen -41.45% over the past one year. While a 52-week high of $5.31 was reached on 06/03/25, a 52-week low of $1.84 was recorded on 04/09/25.
Levels Of Support And Resistance For ACHV Stock
The 24-hour chart illustrates a support level at 2.92, which if violated will result in even more drops to 2.85. On the upside, there is a resistance level at 3.11. A further resistance level may holdings at 3.23.
